Matt McAviney

Dr. McAviney is a Partner at NEA focused on biopharma investments. Prior to NEA, Dr. McAviney was a Principal at F-Prime Capital Partners. During his five years at F-Prime, he was responsible for closing investments in more than 20 private biopharma companies and served on the board of more than 10 portfolio companies. Prior to F-Prime, he was a management consultant in the health and life sciences practice at Oliver Wyman, a biotech equity research analyst at Robert W. Baird, and a healthcare investment banker at JP Morgan. Dr. McAviney also conducted lipid metabolism research at the National Institute of Diabetes, Digestive, and Kidney Disorders.

Dr. McAviney received a BA with Honors in Biological Sciences from the University of Chicago, an MD from the University of Illinois, and an MBA from the University of Chicago Booth School of Business.